Search

everythinglearnresearchcommunity

for

Search:↓

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.

Temporary hair loss can occur after 5-fluorouracil treatment for keloids.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Cancer treatments can cause hair loss, but it is often reversible and can be managed with scalp cooling and support.

A botanical extract may help manage hair loss from chemotherapy by preventing cell death in hair follicles.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Removing lymph nodes does not improve survival for advanced ovarian cancer and may cause more complications.

Intralesional dutasteride improves hair growth in androgenic alopecia with minimal side effects.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

Dutasteride may help reduce brain inflammation and improve cognition.

Dutasteride may help prevent prostate cancer, but more research is needed.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Metyrapone effectively stabilizes severe Cushing's disease symptoms before surgery.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Abatacept may help some people with alopecia areata regrow hair.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Dutasteride is safe and effective for treating hair loss, but may decrease libido.

Adipose-derived stem cell-conditioned medium can reduce melanoma cell growth and spread.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.